Dr Katherine Payne

Katherine Payne’s main research interests are the development and application of economic methods to evaluate both genetics-related services and technologies, such as pharmacogenetic tests, and explore factors affecting their uptake in the NHS. Her research programme includes evaluating the appropriateness of outcome measures in genetics services and developing stated preference tools for genetics services.
She is a qualified pharmacist with a Diploma in Clinical Pharmacy and experience of working as a hospital pharmacist. She has an MSc in Health Economics (University of York). In 1994, she started work in the Academic Pharmacy Practice Unit, The University of Manchester, where her main research interests were the deregulation of medicines and the management of migraine. In 2000, she completed her PhD examining the managed entry of new drugs.
She was the project co-ordinator for an NHS Health Technology Assessment-funded economic evaluation of anaesthetics for day case surgery.
From July 2001, Katherine worked for Health Economics Research at Manchester (HERMAN) on examining preferences for equity of access and health gain for joint replacement surgery; and a systematic review and economic evaluation of strategies for the prevention of non-steroidal anti-inflammatory induced gastrointestinal toxicity. Katherine’s commitments within Nowgen include teaching health economics to pharmacists (Universities of Manchester and London). In October 2003, Katherine became a member of an NICE Appraisal Committee. In September 2007, Katherine started an RCUK academic fellowship in health economics entitled ‘the economics of genetics services and technologies (EGENTECH)’. She is now a member of Health Economics Research at Manchester in the Health Methodology Research Group but continues to have close links with Nowgen through her research programme.